Insider Transactions Reported by 18 Insiders of BridgeBio Oncology Therapeutics, Inc.

Symbol
BBOT on Nasdaq
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

BridgeBio Oncology Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bihua Chen Director, 10%+ Owner $191,610,255 11 Aug 2025
BridgeBio Pharma LLC 10%+ Owner $156,363,757 10 Oct 2025
Pedro Beltran Chief Scientific Officer $561,906 10 Mar 2026
Yong Ben Chief Med & Dev Officer $561,906 10 Mar 2026
Albert A. Holman III Former Director $321,519 11 Aug 2025
Mark C. McKenna Former Director $321,519 11 Aug 2025
John P. Schmid Former Director $321,519 11 Aug 2025
Uneek Mehra Chief Financial Officer $280,893 10 Mar 2026
Michelle Doig Director 11 Aug 2025
Praveen P. Tipirneni Director 26 Aug 2025
Eli M. Wallace Chief Executive Officer, Director 01 Jan 2026
Neil Kumar Director 11 Aug 2025
Jake Bauer Director 26 Aug 2025
Frank Mccormick Director 26 Aug 2025
Raymond J. Kelleher Director 11 Aug 2025
Caleb Tripp Chief Financial Officer 11 Aug 2025
Helix Holdings II LLC Director, 10%+ Owner 08 Feb 2025
Nebojsa Obradovic Chief Legal Officer 11 Aug 2025

Recent Insider Transactions by Companies or Individuals for BridgeBio Oncology Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Uneek Mehra BBOT Common Stock Award 23,330 23,330 10 Mar 2026 Direct
Uneek Mehra BBOT Stock Option (Right to Buy) Award 105,000 105,000 10 Mar 2026 Direct
Pedro Beltran BBOT Common Stock Award 46,670 46,670 10 Mar 2026 Direct
Pedro Beltran BBOT Stock Option (Right to Buy) Award 210,000 210,000 10 Mar 2026 Direct
Yong Ben BBOT Common Stock Award 46,670 46,670 10 Mar 2026 Direct
Yong Ben BBOT Stock Option (Right to Buy) Award 210,000 210,000 10 Mar 2026 Direct
Eli M. Wallace HLXB Stock Option (Right to Buy) Award 1,114,400 1,114,400 01 Jan 2026 Direct
Eli M. Wallace HLXB Stock Option (Right to Buy) Disposed to Issuer -69% -1,114,400 500,000 10 Dec 2025 Direct
BridgeBio Pharma LLC HLXB Common Stock Other 5.68% 784,720 14,589,846 10 Oct 2025 Direct
Eli M. Wallace HLXB Stock Option (Right to Buy) Award 1,614,400 1,614,400 02 Oct 2025 Direct
Praveen P. Tipirneni HLXB Stock Option (Right to Buy) Award 52,269 52,269 26 Aug 2025 Direct
Frank Mccormick HLXB Stock Option (Right to Buy) Award 91,076 91,076 26 Aug 2025 Direct
Jake Bauer HLXB Stock Option (Right to Buy) Award 138,193 138,193 26 Aug 2025 Direct
Pedro Beltran HLXB Stock Option (Right to Buy) Award 357,177 357,177 26 Aug 2025 Direct
Yong Ben HLXB Stock Option (Right to Buy) Award 357,177 357,177 26 Aug 2025 Direct
Eli M. Wallace HLXB Stock Option (Right to Buy) Award 499,731 499,731 26 Aug 2025 Direct
Uneek Mehra HLXB Stock Option (Right to Buy) Award 633,570 633,570 26 Aug 2025 Direct
Bihua Chen HLXB Common Stock Award 1,905,046 1,905,046 11 Aug 2025 Via Fund IV
Bihua Chen HLXB Common Stock Award 8481.8% 5,882,996 5,952,356 11 Aug 2025 Via Master Fund
Bihua Chen HLXB Common Stock Award 265.8% 2,401,870 3,305,470 11 Aug 2025 Via Fund V
Bihua Chen HLXB Common Stock Award 53.3% 760,496 2,187,536 11 Aug 2025 Via Fund III
Bihua Chen HLXB Common Stock Disposed to Issuer -3.27% -152,940 4,528,186 11 Aug 2025 Via Helix Holdings II LLC
Bihua Chen HLXB Common Stock Options Exercise 819.7% 4,172,126 4,681,126 11 Aug 2025 Via Helix Holdings II LLC
Bihua Chen HLXB Class B ordinary shares Options Exercise -100% -4,172,126 0 11 Aug 2025 See footnote
Bihua Chen HLXB Class B ordinary shares Disposed to Issuer -6.87% -307,874 4,172,126 11 Aug 2025 See footnote
Albert A. Holman III HLXB Common Stock Options Exercise 30,000 30,000 11 Aug 2025 Direct
Albert A. Holman III HLXB Class B ordinary shares Options Exercise -100% -30,000 0 11 Aug 2025 Direct
Mark C. McKenna HLXB Common Stock Options Exercise 30,000 30,000 11 Aug 2025 Direct
Mark C. McKenna HLXB Class B ordinary shares Options Exercise -100% -30,000 0 11 Aug 2025 Direct
John P. Schmid HLXB Common Stock Options Exercise 30,000 30,000 11 Aug 2025 Direct
John P. Schmid HLXB Class B ordinary shares Options Exercise -100% -30,000 0 11 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.